The Second People's Hospital of Sichuan   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Chengdu Sichuan China (1892)

Organization Overview

First Clinical Trial
2011
NCT01410214
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

LANG Jin-yi

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Squamous Cell (Phase 3)

Esophageal Neoplasms (Phase 3)

Esophageal Squamous Cell Carcinoma (Phase 3)

Hypopharyngeal Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Oropharyngeal Neoplasms (Phase 2)

Stomach Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 8